These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31566439)

  • 1. What are the challenges in commercial non-tuberculous mycobacteria (NTM) drug discovery and how should we move forward?
    Timmins GS
    Expert Opin Drug Discov; 2020 Jan; 15(1):7-9. PubMed ID: 31566439
    [No Abstract]   [Full Text] [Related]  

  • 2. NTM drug discovery: status, gaps and the way forward.
    Wu ML; Aziz DB; Dartois V; Dick T
    Drug Discov Today; 2018 Aug; 23(8):1502-1519. PubMed ID: 29635026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria.
    Soni I; De Groote MA; Dasgupta A; Chopra S
    J Med Microbiol; 2016 Jan; 65(1):1-8. PubMed ID: 26515915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 5. Medications and monitoring in nontuberculous mycobacteria infections.
    Egelund EF; Fennelly KP; Peloquin CA
    Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Genomics Approach for Shortlisting Broad-Spectrum Drug Targets in Nontuberculous Mycobacteria.
    Swain A; Gnanasekar P; Prava J; Rajeev AC; Kesarwani P; Lahiri C; Pan A
    Microb Drug Resist; 2021 Feb; 27(2):212-226. PubMed ID: 32936741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Tuberculous Mycobacteria: Classification, Diagnostics, and Therapy.
    Porvaznik I; Solovič I; Mokrý J
    Adv Exp Med Biol; 2017; 944():19-25. PubMed ID: 27826888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections.
    Sethiya JP; Sowards MA; Jackson M; North EJ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycobacterial strategies to evade antimicrobial resistance in the nontuberculous mycobacteria.
    Millar BC; Moore JE
    Int J Mycobacteriol; 2019; 8(1):7-21. PubMed ID: 30860173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-art treatment strategies for nontuberculous mycobacteria infections.
    Muñoz-Egea MC; Carrasco-Antón N; Esteban J
    Expert Opin Pharmacother; 2020 Jun; 21(8):969-981. PubMed ID: 32200657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria.
    Brown-Elliott BA; Woods GL
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31315954
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of nontuberculous mycobacterial (NTM) lung disease.
    Philley JV; Griffith DE
    Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital in South India.
    Jesudason MV; Gladstone P
    Indian J Med Microbiol; 2005 Jul; 23(3):172-5. PubMed ID: 16100423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases.
    Huh HJ; Kim SY; Jhun BW; Shin SJ; Koh WJ
    Infect Genet Evol; 2019 Aug; 72():169-182. PubMed ID: 30315892
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Brown-Elliott BA; Rubio A; Wallace RJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nontuberculous mycobacteria infections in immunosuppressed hosts.
    Henkle E; Winthrop KL
    Clin Chest Med; 2015 Mar; 36(1):91-9. PubMed ID: 25676522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
    Camarena Miñana JJ; Pellicer RG
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.